| Financial Year |
September 30 2020 |
| Monetary Funds |
10,985,937,318.04 |
| Held-for-trading Financial Assets |
205,700,000.00 |
| Notes Receivable |
135,114,365.76 |
| Accounts Receivable |
31,346,919,261.38 |
| Advances to Suppliers |
2,922,187,086.56 |
| Other Receivables |
4,321,116,047.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,656,484,110.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
17,174,602.07 |
| Other Current Assets |
345,636,775.60 |
| Total Current Assets |
64,916,663,603.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,268,102.77 |
| Long-term Equity Investment |
1,741,204,598.56 |
| Investment Properties |
282,364,160.96 |
| Fixed Assetes |
5,536,430,274.23 |
| Under-construction Projects |
1,474,653,771.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,273,279,506.98 |
| R&D expenses |
6,544,581.07 |
| Goodwill |
535,546,341.80 |
| Long-Term Deferred and Prepaid Expenses |
104,520,547.14 |
| Deferred Income Tax Assets |
229,494,981.21 |
| Other Non-Current Assets |
16,741,444.59 |
| Sub-Total of Non-Current Assets |
13,799,993,314.98 |
| Total Assets |
78,716,656,918.62 |
| Short-Term Loans |
13,287,901,991.45 |
| Trading Financial liabilities |
353,205,426.18 |
| Notes Payable |
14,475,845,475.56 |
| Accounts Payable |
15,411,363,671.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
158,493,006.81 |
| Taxes Payable |
419,067,337.55 |
| Interest Payable |
45,958,256.62 |
| Dividend Payable |
1,537,691.49 |
| Other payables |
3,574,644,647.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,000,000.00 |
| Other Current Liabilities |
1,638,525,320.99 |
| Sub-Total of Current Liabilities |
50,235,330,933.34 |
| Long-term Loans |
1,402,992,605.15 |
| Bonds Payable |
1,461,160,469.24 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
291,206,629.81 |
| Other Non-Current Liabilities |
186,220,200.00 |
| Sub-Total of Non-Current Liabilities |
3,571,250,097.45 |
| Total Liabilities |
53,806,581,030.79 |
| Paid-In Capital(Or Share Stock) |
1,873,810,877.00 |
| Capital Surplus |
8,054,802,323.22 |
| Surplus Reserve |
573,371,700.83 |
| LESS:Treasury Stock |
596,817,592.89 |
| Undistributed Profits |
8,645,888,911.01 |
| Minority Stockholder's Interest |
3,903,595,513.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,006,480,374.47 |
| Owner's Equity（Stockholder's Equity） |
24,910,075,887.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
78,716,656,918.62 |
